Skip to content
Sunday, October 11, 2026
Focus Network

Individuals Stopping Slimming Medications Gain Back Weight at a Quadrupled Rate Than Dieters

Illustration of medical syringe and scale
Weight management often requires ongoing approaches.

A recent study indicates that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who stop traditional lifestyle regimens.

Research printed in a prominent health publication shows that while overweight individuals can lose a large proportion of their total mass while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"People using these medications should be aware of the danger of rapid rebound weight gain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.

This pace of recovery implies a reversion to original mass within about one and a half years.

Comparing Approaches

The study, which looked at 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.

Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally experience a slower creep back—perhaps 0.1 kg a month—after stopping.

Explaining the Quick Regain

Nutrition scientists believe the mechanism of the injections accounts for the accelerated rebound.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication results in hunger is no longer kept in check, making binge eating far more likely."

A Lifelong Issue?

The NHS recommend the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, given the likelihood of weight regain, the treatment should be considered long-term.

This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the long-term character of excess weight," akin to managing conditions like hypertension.

Patient Testimonies

People who have come off the medication explain a intense return of hunger.

"I experienced a trigger activating and you're instantly ravenous," said an individual.

The struggle is worsened if patients have not established lasting lifestyle or habit modifications during treatment.

Widespread Adoption

Survey data show that millions of adults in the UK have used these injections in the last 12 months, with demand being substantial.

  • Use is higher among women compared to men.
  • The 40s and 50s age group shows the greatest usage rates.
  • A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while these medications are powerful agents for weight loss, they are not a permanent cure and long-term success relies on combined lifestyle changes.

SM
The writer

Steven Moore

A seasoned business strategist with over a decade of experience in helping startups scale and thrive in competitive markets.

Focus Network

Type to search articles.